Recovery ⏱ Half-life: Very short.

Vilon

Vilon (KE Dipeptide)

Buy from $24.99 →
Half-Life
Very short.
Mol. Weight
~275 g/mol

What is Vilon?

Vilon is the shortest peptide in the bioregulator series — just two amino acids — yet demonstrates targeted effects on thymic tissue and immune function.

Research Applications

Immune restoration, thymic function, T-cell support, and immunosenescence research.

Dosage Information (Research Use)

10-20 mg/day for 10-30 day courses. Research use only.

Reconstitution & Handling

Standard.

Half-Life & Pharmacokinetics

Very short.

Reported Observations in Literature

Generally well-tolerated.

Key Research References

  • Khavinson VK, et al. “AEDG peptide regulates gene expression.” Bull Exp Biol Med. 2005

How Vilon Works

Vilon is the smallest known peptide bioregulator (dipeptide). It targets thymic tissue gene expression, supporting T-cell differentiation and immune function restoration.

Research Findings

Studied alongside Thymalin for immune reconstitution. Remarkable that a dipeptide can have targeted biological effects.

Dosage & Administration

10-20 mg/day for 10-30 day courses. Research use only.

Safety & Side Effects

Generally well-tolerated.

Important: All safety information is derived from published research, primarily animal studies. No controlled human clinical trial data exists unless explicitly noted. This compound is sold for research purposes only.

Quick Facts

Sequence Lys-Glu
Molecular Weight ~275 g/mol
Half-Life Very short.
Available Sizes 5mg
Storage Lyophilized: -20°C.

Key Research References

  • Khavinson VK, et al. "AEDG peptide regulates gene expression." Bull Exp Biol Med. 2005

Get Vilon from SourcePeptides

Third-party tested • Research-grade purity • Fast US shipping

Shop Now →

Related Peptides

View all →
Recovery
Gastric pentadecapeptide researched for tissue repair, gut healing, and accelerated recovery across multiple tissue types.
Recovery
FDA-approved synthetic analog of PTHrP that promotes bone formation and reduces fracture risk in postmenopausal osteoporosis.
Recovery
Long-acting somatostatin analog for acromegaly and neuroendocrine tumors with convenient self-injectable depot formulation.